AU7327298A - Use of a pharmaceutical composition for treating and/or preventing ischemia - Google Patents

Use of a pharmaceutical composition for treating and/or preventing ischemia

Info

Publication number
AU7327298A
AU7327298A AU73272/98A AU7327298A AU7327298A AU 7327298 A AU7327298 A AU 7327298A AU 73272/98 A AU73272/98 A AU 73272/98A AU 7327298 A AU7327298 A AU 7327298A AU 7327298 A AU7327298 A AU 7327298A
Authority
AU
Australia
Prior art keywords
treating
pharmaceutical composition
preventing ischemia
ischemia
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73272/98A
Inventor
Carine Michiels
Jose Remacle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7327298A publication Critical patent/AU7327298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU73272/98A 1997-05-13 1998-05-12 Use of a pharmaceutical composition for treating and/or preventing ischemia Abandoned AU7327298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700415A BE1011151A3 (en) 1997-05-13 1997-05-13 Use of a pharmaceutical composition for treating and / or preventing ischemia.
BE9700415 1997-05-13
PCT/BE1998/000067 WO1998051291A1 (en) 1997-05-13 1998-05-12 Use of a pharmaceutical composition for treating and/or preventing ischemia

Publications (1)

Publication Number Publication Date
AU7327298A true AU7327298A (en) 1998-12-08

Family

ID=3890512

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73272/98A Abandoned AU7327298A (en) 1997-05-13 1998-05-12 Use of a pharmaceutical composition for treating and/or preventing ischemia

Country Status (7)

Country Link
EP (1) EP0981339A1 (en)
JP (1) JP2001526658A (en)
AU (1) AU7327298A (en)
BE (1) BE1011151A3 (en)
CA (1) CA2287363A1 (en)
NO (1) NO995500L (en)
WO (1) WO1998051291A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792203B1 (en) * 1999-04-19 2003-05-16 Mu Laboratoire NOVEL COMPOSITION BASED ON NATURAL PLANT EXTRACTS, AND ITS USE, PARTICULARLY IN THE PHARMACEUTICAL OR COSMETIC FIELDS
FR2796552A1 (en) 1999-07-21 2001-01-26 Centre Nat Rech Scient NOVEL USE OF BETA-NAPHTOQUINONE DERIVATIVES AND THEIR SALTS FOR THE MANUFACTURE OF MEDICINES HAVING AN INHIBITOR EFFECT ON THE RELEASE OF GLUTAMATE IN THE BRAIN
FR2802425B1 (en) 1999-12-21 2003-09-26 Oreal USE OF AN EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY AS AN ANTI-GLYCATION AGENT
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
FR2814950B1 (en) * 2000-10-05 2003-08-08 Oreal USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY, IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING
DE10122715A1 (en) * 2001-05-10 2002-11-21 Brench Ag Use of rutines and escines for the treatment of auricular circulatory disorders
DE10122714A1 (en) * 2001-05-10 2002-11-21 Brench Ag Combination of a rutin and aescin for treating ocular disorders associated with altered blood circulation, e.g. glaucoma or edema
EP1382327A1 (en) * 2002-07-17 2004-01-21 Cognis France S.A. Method of protection of the skin against ageing
EP1382326A1 (en) * 2002-07-17 2004-01-21 Cognis France S.A. Method of protecting the skin against ageing
FR2844716B1 (en) * 2002-09-23 2008-11-21 Marcel Jacques Chicouri NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR FOOD HYGIENE OF DIABETICS
JP4562365B2 (en) * 2003-09-19 2010-10-13 株式会社ノエビア Health promotion composition
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
EP1588705A1 (en) * 2004-04-21 2005-10-26 INTE:LIGAND Software-Entwicklungs und Consulting GmbH Use of coumarin derivatives
EP1607006A1 (en) * 2004-06-18 2005-12-21 Unilever N.V. Functional berry composition
WO2007005879A2 (en) * 2005-07-01 2007-01-11 The Johns Hopkins University Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
FR2904222A1 (en) 2006-07-27 2008-02-01 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES
KR100880876B1 (en) * 2007-04-11 2009-01-30 경상대학교산학협력단 Pharmaceutical composition for the prevention and treatment of the ischemia-reperfusion injury in the flaps or tissues containing anthocyanin extracted from the Black soybean seed coat
DE102007033067A1 (en) * 2007-07-13 2009-01-15 Institut für Umweltmedizinische Forschung gGmbH Preparations for improving the protection of human cells, in particular cells of the human skin against damaging influences by oxidative noxious agents and UV irradiation
EP2014276A1 (en) 2007-06-20 2009-01-14 Cognis IP Management GmbH Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD3986C2 (en) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
MD4231C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
CN110585222B (en) * 2019-10-12 2023-05-09 西南医科大学 Application of aescin compound in preparation of medicines
IT202000010924A1 (en) * 2020-05-13 2021-11-13 Neilos S R L "COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE CIRCULATORY SYSTEM AND RELATED SYMPTOMS"
CN112138015B (en) * 2020-10-22 2022-08-05 合肥博思科创医药科技有限公司 Application of tribenoside in treating skin diseases caused by microcirculation disturbance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623255A1 (en) * 1986-07-10 1988-01-21 Oxo Chemie Gmbh Pharmaceutical composition for preventing oxidative damage to blood vessels
DE3808835A1 (en) * 1987-03-27 1988-10-06 Sandoz Ag Pharmaceutical composition containing a mixture of dihydroergotamine, etilefrine and troxerutin
FR2707495B1 (en) * 1993-07-02 1995-09-01 Roussel Uclaf New use of beta-naphthoquinone derivatives and their salts.
FR2726469B1 (en) * 1994-11-08 1996-12-13 Adir PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS

Also Published As

Publication number Publication date
EP0981339A1 (en) 2000-03-01
JP2001526658A (en) 2001-12-18
BE1011151A3 (en) 1999-05-04
CA2287363A1 (en) 1998-11-19
WO1998051291A1 (en) 1998-11-19
NO995500D0 (en) 1999-11-10
NO995500L (en) 1999-11-10

Similar Documents

Publication Publication Date Title
AU7327298A (en) Use of a pharmaceutical composition for treating and/or preventing ischemia
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
HK1025904A1 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
AU4398296A (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
AU5880498A (en) New benzolactam derivatives and medicinal compositions containing the same
AU9317298A (en) Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
AU1592299A (en) Skin rash prevention composition
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AUPN801196A0 (en) New cephem compounds and pharmaceutical use thereof
AU1454599A (en) Compounds inhibiting cd4-gp120 interaction and uses thereof
AU5272399A (en) Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical
AU8695298A (en) Compounds and uses thereof
AP9901675A0 (en) Pharmaceutical compositions or tizoxanide and nitazoxanide
AU5270693A (en) Pharmaceutical composition for preventing or treating arteriosclerosis
AU732214C (en) Biphenyl derivatives and drug composition
AU6251098A (en) Composition for use as a fungistat and for the treatment of fungal infections
AU5531798A (en) Pharmacologically active compounds and use
AU7681498A (en) Pharmaceutical composition and use thereof
AU4107797A (en) Compounds for the treatment and prevention of diabetes
AU8031698A (en) Indane compounds and their pharmaceutical use
IL120199A (en) Diaryl alkane derivatives containing a heterocyclic group and pharmaceutical compositions containing the same
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase